AKT1 and colorectal carcinoma: MIR133A deactivates the PI3K/AKT pathway in CRC cell lines, and PI3K/AKT inhibits GSK3B and promotes cyclin D1 to increase its transcriptional activity, ultimately increasing GSK3B and decreasing CTNNB1 16,39.